|
Post by peppy on Apr 7, 2018 15:39:07 GMT -5
Will MNKD post; The ADA STAT STUDY presentation to be on the new Afrezza you tube channel?
|
|
|
Post by stockwhisperer on Apr 7, 2018 20:03:48 GMT -5
Thanks to to the person or people putting this together for consideration of my questions.
Q1: It seems that Seeking Alpha, Motley Fool and other articles hit on a regular basis - contradicting what the CEO last said and containing volumes of detailed data, thoroughly promoting negativity. What can MNKD do on a regular basis, to be more actively engaged w/the public - investors via PR, etc., between quarterly reports to help counter these destructive situations?
Q2: Short sellers love the weekly Friday script count game while Long investors hope for big numbers, cringing in anticipation. Can you please provide details on how you determine / calculate these numbers - scripts, refills, etc., so the numbers / data on message boards, articles, etc., each week can be better understood and known to match how you do it internally? Could the script data be provided by MNKD on a weekly basis with a brief comment / explanation, as necessary to help ensure accuracy?
Q3: As quickly as the CEO says no bankruptcy for MNKD, shorts continue to yell it and articles imply it. What they say / write, seems twisted w/lengthly verbiage and data to support the short seller’s thesis. How can this be addressed - outside of quarterly meetings, to help current shareholders and entice future investors.
Q4: Do you think ‘naked shorting’ is a serious problem for MNKD. If yes, is anyone in the company actively working with the SEC to do something about it? If yes, when do you anticipate SEC action?
|
|
|
Post by stockwhisperer on Apr 7, 2018 21:25:28 GMT -5
Another question, based on something I just read. Thank you
Q: I agree w/the following comment written by an investor saying that 2018 is a story of growth & partnerships. With that in mind, he further stated, “Future cash injections should not come from financial investors, but rather from industry/strategic partners.” Will this be the case?
|
|
|
Post by peppy on Apr 8, 2018 7:58:32 GMT -5
Another question; Is MNKD/ Afrezza making in roads into any hospital pharmacies?
We know nothing would be better to control blood glucose levels in a hospital setting. "Get them by the.... mg/dl?" "Get them by the possible pharmacy revenue generated on a per dose basis? plus the one time Spirometry. The hospitals can not lose.
Are any of our MNKD sales representatives being seen by hospital products evaluation/purchasing committees?
|
|
|
Post by bigkid53 on Apr 8, 2018 10:43:01 GMT -5
Hospitals ok, but nursing homes even better. Staff has to shoot up numerous patient everyday.. Afrezza will save time and pain, cut down on resistance, and improve outcomes for thousands of patients.
|
|
|
Post by sportsrancho on Apr 9, 2018 11:27:44 GMT -5
I would like to know how we are going to stop this!
|
|
|
Post by dreamboatcruise on Apr 10, 2018 13:46:50 GMT -5
Will MNKD post; The ADA STAT STUDY presentation to be on the new Afrezza you tube channel? If the youtube channel is something they are using in patient focused marketing then I don't believe they could put the STAT study presentation on it since that would not be FDA approved for consumer marketing.
|
|
|
Post by dreamboatcruise on Apr 10, 2018 13:55:44 GMT -5
I would like to know how we are going to stop this! Unlikely it can be stopped, but the positive side of the double edged reality of twitter posts about Afrezza (i.e. very few patients or medical professionals see this stuff) is that his posts are likely to have no effect on success of Afrezza. I think it mostly the warring MNKD stock longs and shorts that are looking for #afrezza stuff on twitter.
|
|
|
Post by boca1girl on Apr 10, 2018 14:01:42 GMT -5
I would like to know how we are going to stop this! I would think the originator could file a complaint with Twitter if the comments were in violation with Twitter’s policies.
|
|
|
Post by sportsrancho on Apr 10, 2018 14:08:48 GMT -5
I would like to know how we are going to stop this! Unlikely it can be stopped, but the positive side of the double edged reality of twitter posts about Afrezza (i.e. very few patients or medical professionals see this stuff) is that his posts are likely to have no effect on success of Afrezza. I think it mostly the warring MNKD stock longs and shorts that are looking for #afrezza stuff on twitter. I realize it has no effect on the stock, it hurts me for these people, their lives have enough stress! I hate to see it, I hate to see Sam harassed and the new people called liars ...they’re not familiar with shorts, they don’t know that it’s about the stock! Just hurts my heart.
|
|
|
Post by dreamboatcruise on Apr 10, 2018 14:13:15 GMT -5
Unlikely it can be stopped, but the positive side of the double edged reality of twitter posts about Afrezza (i.e. very few patients or medical professionals see this stuff) is that his posts are likely to have no effect on success of Afrezza. I think it mostly the warring MNKD stock longs and shorts that are looking for #afrezza stuff on twitter. I realize it has no effect it on the stock, it hurts me for these people, their lives have enough stress! I hate to see it, I hate to see Sam harassed and the new people called liars ...they’re not familiar with shorts, they don’t know that it’s about the stock! Just hurts my heart. I also hate to see people called liars... I can almost imagine what that is like But agree that having patients trying to share their experiences (mostly great experiences, but even the occasional less than great) being attacked is pretty distasteful.
|
|
|
Post by sportsrancho on Apr 10, 2018 18:13:50 GMT -5
From Gary......LeAnne can you ask the folks on PB for their final questions to be submitted for the annual shareholders meeting? I will put them together and forward them to Mike. We will see if he will address them. Would like to have them by the end of this week. Thanks.
|
|
|
Post by peppy on Apr 10, 2018 22:58:21 GMT -5
From Gary......LeAnne can you ask the folks on PB for their final questions to be submitted for the annual shareholders meeting? I will put them together and forward them to Mike. We will see if he will address them. Would like to have them by the end of this week. Thanks. Afrezza as Standard of care. What is the plan? Type one, type two. Endo, General Care physician? How do you plan to increase scripts and what do your next 12 month projections for weekly scripts look like? What are your projections to break even? In other words, how long until we reach break even? Is MNKD running Afrezza commercials on television screens in physician offices? (Outcome Health for in physician's waiting room TV Advertising.) what does your overall advertising promotional campaign look like moving forward and what type of media mix do you plan? What are the fixed manufacturing costs per unit, and what are the variable manufacturing costs per unit. The "unit" can be any measure they like, but one box in the new configuration is probably the most sensible. we are charging $.79 a unit? what is a Mannkind Cares Pharmacy and are titration packs available only at such a pharmacy? What is the refill rate look like over the last two years and what is the projection going forward? Also what are the action items to improve refill rates? Even thought the estimated Primary Completion Date is July 2020, I would be interested in learning when there might be preliminary information released by the company related to the pediatric trial (ClinicalTrials.gov Identifier: NCT02527265). Might we hear something as early as Spring/Summer of 2019? What exactly do they hope to accomplish and what results do they expect to see with the reveal of the stat study results? What is the status of the 1-2 international deals that Mike has brought up twice (1 signed term sheet, 1 soon to be signed)? What is being done to drive domestic sales of Afrezza? Status of pipeline, particularly Trepostinil. Is Epipen competitor dead? What specifically is being done to increase insurance coverage and what is the timetable for full coverage (eg: coverage comparable to our competitors) What is up with RLS and will it ever bear fruit? What ever happened to Torrey Pines and the pain patents. Why didn't this get any traction? What 60 found Afrezza studies? From? Are they published, unpublished? Will they be published? How are you planning to use them? What are you thinking regarding over the counter possibilities for afrezza sales? What were the results from the targeted DTC ads that were run in select markets and how will this information be leveraged.? Do you plan on any more dilutive cap raises this year? Do sales teams/representatives visit PBM? Insurance companies? Can Mike and team tell us anything about the STAT results? If so what can MNKD/Mike/Team tell tells? What is the plan for STAT study result presentation? Detailed please. The ADA STAT STUDY presentation to be posted on the internet? Is MNKD/ Afrezza making in roads into any hospital pharmacies? Read more: mnkd.proboards.com/thread/9774/shareholder-management-team?page=1#ixzz5CKhuWxTx
|
|
|
Post by buyitonsale on Apr 11, 2018 0:27:12 GMT -5
Many shareholders believe that the stock is grossly undervalued. What do you believe is a fair market cap valuation?
What do you think is a single and most important event / milestone fthe market is waiting for that would trigger a stock price move to that fair valuation?
|
|
|
Post by joeypotsandpans on Apr 11, 2018 7:33:07 GMT -5
Unlikely it can be stopped, but the positive side of the double edged reality of twitter posts about Afrezza (i.e. very few patients or medical professionals see this stuff) is that his posts are likely to have no effect on success of Afrezza. I think it mostly the warring MNKD stock longs and shorts that are looking for #afrezza stuff on twitter. I realize it has no effect on the stock, it hurts me for these people, their lives have enough stress! I hate to see it, I hate to see Sam harassed and the new people called liars ...they’re not familiar with shorts, they don’t know that it’s about the stock! Just hurts my heart. I would imagine that those who even read anything from him/her do so from a humor standpoint along with others in the same modus operandi....Sports, even SO accused me of lying or as he used his euphemism "hyperbole" regarding the four physicians not even mentioning anything regarding a spirometry to me in the last two years. One doesn't take ignorance personally rather interprets it as it confirms either desperation, defensiveness, stupidity or a combination of all three
|
|